Eli Lilly Stock Plummets After Earnings Miss. Weight-Loss Drug Sales Fell Short. - Barron's


10/30/2024

Eli Lilly Stock Plummets After Earnings Miss. Weight-Loss Drug Sales Fell Short.  Barron'sEli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance  CNBCLilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products  Investors | Eli Lilly and CompanyEli Lilly stock tumbles on Q3 miss from Zepbound shortfall  Yahoo FinanceEli Lilly's weight-loss drug misses Wall Street expectations, shares tumble  Reuters...

Original

Categories: Earnings | Financial | Revenue | Stock

Tags: barron's | drug | earnings | financial | giant | miss | profit | reports | results | sales | shares | stock | street | strong | wall



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top